Studies have shown markedly higher rates of osteopenia and osteoporosis in people with HIV compared with the general population and the exact causes of this and the best treatments to be used have been the subject of some debate.
Treatment side effects
Darunavir and the risk of hepatitis
From the July 2008 issue of Positive Living
A warning has been issued by Tibotec, the manufacturers of Prezista (darunavir) regarding the risk of developing drug- induced hepatitis while taking the treatment.
Managing side effects
This booklet is for people with HIV who experience side effects from HIV treatments or other physical symptoms that may be due to HIV infection. It will help you identify side effects, and provides suggestions on how to prevent, manage, reduce or eliminate some common side effects.
Lipo: any progress?
From the December 2007 issue of Positive Living
While newer antiretrovirals do not appear to cause lipoatrophy, the disfiguring side effect characterised by loss of fat from the face and limbs, the problem is still very much with us. David Menadue examins the latest research and treatments.
ASHM 2006: Spotlight on Sculptra
From the December 2006 issue of Positive Living
The annual conference of the Australasian Society for HIV Medicine (ASHM) was held in Melbourne in November. This article summarises some key developments. Lipoatrophy: options for preventing, managing and treating fat loss associated with HIV treatments (updated)
Fact Sheet • By: Brent Beadle • 26 June 2006 - 11:38am
A Treataware fact sheet on Lipoatrophy – the loss or ‘wasting’ of fat from the face, as well as sometimes the buttocks, upper arms legs or thighs. Options for prevention, treatment and management of fat loss associated with HIV treatments.
Viral rebound: How stop-start spelled the end for SMART
From the April 2006 issue of Positive Living
The sudden cancellation of a large HIV clinical study has significant implications for how we treat HIV. KIRSTY MACHON reports.
Factors to discuss with your doctor when considering your choice of Antiretroviral Drugs
Fact Sheet • By: Brent Beadle • 11 November 2005 - 11:03am
This Treataware fact sheet is a quick reference to the factors people with HIV and their doctors need to consider when choosing an antiretroviral treatment regimen.
My toxic world
From the August 2005 issue of Positive Living
The beautiful beaches of Rio de Janeiro are hardly the place in which you’d imagine your thoughts would start turning to mortality, but for a while there not even the incredible, hunky, tanned Adonises strutting before me could distract me from thoughts of impending doom.
The bleeding edge
From the April 2005 issue of Positive Living
The annual Retrovirus Conference is a key event on the HIV scientific calendar, and regularly highlights the most exciting ‘bleeding edge’ developments from the world of HIV science.